Shares of Phibro Animal Health Corporation (PAHC) surged over 5% in extended trading on Wednesday, following the company's impressive fiscal second-quarter results and an upbeat full-year revenue forecast.
For the quarter ended December 31, 2024, Phibro reported adjusted earnings per share of $0.54, comfortably beating analysts' expectations of $0.42. The animal health and mineral nutrition company's revenue grew nearly 24% year-over-year to $309.3 million, also exceeding consensus estimates of $303.84 million.
Notably, Phibro raised its fiscal 2025 revenue guidance to a range of $1.25 billion to $1.30 billion, compared to analysts' average projection of $1.32 billion. The company cited strong demand across its animal health and nutrition businesses for the upbeat outlook.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。